Clinical Trial: Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07438925) titled 'Copeptin Concentration Measured in Plasma Samples and Intradialytic Blood Pressure Variation' on Feb. 11.

Brief Summary: Vasopressin is a key regulator of water and vascular homeostasis, acting through V2 receptors to control renal water reabsorption and through V1a receptors to influence vascular tone. Copeptin, a stable surrogate marker of vasopressin release, provides a reliable measure of vasopressin activity. In hemodialysis, where ultrafiltration and osmotic shifts challenge fluid balance, the contribution of vasopressin to intradialytic blood pressure regulation remains uncertain. Elevated copeptin levels in dialysis patients...